All companies › AGIO

AGIO · AGIOS PHARMACEUTICALS, INC.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells2
Research cases0
Last filing2026-10-22

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-10-21 — Gheuens Sarah · sold 1,489 @ $37.53 2026-10-22 — Gheuens Sarah · sold 500 @ $37.52
2026-10-212026-10-22

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Gheuens Sarah Chief Medical Officer
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $AGIO is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-22', 'insider_name': 'Gheuens Sarah', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 500.0, 'price': 37.52, 'value': 18760.0, 'is_buy': False}, {'transaction_date': '2026-10-21', 'insider_name': 'Gheuens Sarah', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 1489.0, 'price': 37.53, 'value': 55882.17, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for AGIO today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.